Corbus Pharmaceuticals Holdings Inc (CRBP)
39.79
+0.97
(+2.50%)
USD |
NASDAQ |
May 07, 16:00
38.01
-1.78
(-4.47%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings 1 Year Total Returns (Daily): 269.4% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 06, 2024 | 269.4% |
May 03, 2024 | 356.1% |
May 02, 2024 | 376.3% |
May 01, 2024 | 339.3% |
April 30, 2024 | 321.9% |
April 29, 2024 | 305.9% |
April 26, 2024 | 345.4% |
April 25, 2024 | 271.8% |
April 24, 2024 | 249.5% |
April 23, 2024 | 326.9% |
April 22, 2024 | 326.5% |
April 19, 2024 | 289.7% |
April 18, 2024 | 204.4% |
April 17, 2024 | 255.3% |
April 16, 2024 | 328.8% |
April 15, 2024 | 345.5% |
April 12, 2024 | 398.2% |
April 11, 2024 | 387.8% |
April 10, 2024 | 381.1% |
April 09, 2024 | 383.5% |
April 08, 2024 | 418.2% |
April 05, 2024 | 425.9% |
April 04, 2024 | 461.5% |
April 03, 2024 | 501.6% |
April 02, 2024 | 415.3% |
Date | Value |
---|---|
April 01, 2024 | 422.6% |
March 28, 2024 | 426.7% |
March 27, 2024 | 421.6% |
March 26, 2024 | 427.7% |
March 25, 2024 | 420.1% |
March 22, 2024 | 424.6% |
March 21, 2024 | 497.0% |
March 20, 2024 | 466.9% |
March 19, 2024 | 589.7% |
March 18, 2024 | 571.3% |
March 15, 2024 | 1.40K% |
March 14, 2024 | 1.37K% |
March 13, 2024 | 1.99K% |
March 12, 2024 | 1.98K% |
March 11, 2024 | 1.69K% |
March 08, 2024 | 1.68K% |
March 07, 2024 | 1.42K% |
March 06, 2024 | 1.08K% |
March 05, 2024 | 1.08K% |
March 04, 2024 | 1.14K% |
March 01, 2024 | 1.15K% |
February 29, 2024 | 933.4% |
February 28, 2024 | 836.5% |
February 27, 2024 | 780.7% |
February 26, 2024 | 918.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.53%
Minimum
Oct 19 2022
1.99K%
Maximum
Mar 13 2024
0.84%
Average
-33.89%
Median
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -14.20% |
Perspective Therapeutics Inc | 177.7% |
Protalix BioTherapeutics Inc | -66.06% |
Electromed Inc | 57.33% |
Armata Pharmaceuticals Inc | 69.59% |